RxDoctor Payments Data

Lance Ledbetter

Optometrist · Moore, OKNPI 1538151337

Payments from drug & device makers

$782in general payments, 2019–2025

Across 12 payments — averaging $65.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Glaukos Corporation$139
  • Sight Sciences, Inc.$127
  • Ocular Therapeutix, Inc.$126
  • Rxsight Inc$120
  • Optos, Inc.$109
  • Alcon$75
  • plus $87 from 2 others

What the payments were for

  • Food & beverage$67386%
  • Entertainment$10914%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Glaukos Corporation2$139
Sight Sciences, Inc.1$127
Ocular Therapeutix, Inc.1$126
Rxsight Inc1$120
Optos, Inc.2$109
Alcon3$75
The Cameron-ehlen Group, Inc.1$72
Johnson & Johnson Vision Care, Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$782 in reported general payments places this provider in the 55th percentile of 714 optometrist providers in Oklahoma.

See all optometrist providers in Oklahoma

Medicare billing

Part B allowed, 2024
$41,539
Medicare patients
281
Services billed
391

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Timolol Maleate11$104

Paid to pharmacies, not to this prescriber.

Other optometrist in Moore

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →